Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DVS XR vs venlafaxine XR in major depressive disorder
CTR20131377Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of desvenlafaxine in major depressive disorder (MDD), sponsored by Hengrui Therapeutics. Started Nov 2014; status: completed.
02
Drugs
desvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20131377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131377.